Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival

Cancer

Volumn 67, Issue 2, 1991, Pages 372-379

  Panici, Pierluigi Benedetti ^a   Scambia, Giovanni ^a   Baiocchi, Gabriela ^a   Greggi, Stefano ^a   Ragusa, Guglielmo ^a   Gallo, Angelo ^a   Conte, Massimo ^a   Battaglia, Francesco ^a   Laurelli, Giuseppe ^a   Rabitti, Carla ^a   Capelli, Arnaldo ^a   Mancuso, Salvatore ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; METHOTREXATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUROTOXICITY; PRIORITY JOURNAL; SURVIVAL; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CERVIX NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMAN; HYSTERECTOMY; LYMPHATIC METASTASIS; METHOTREXATE; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; REMISSION INDUCTION; SURVIVAL RATE;

EID: 0025974114     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19910115)67:2<372::AID-CNCR2820670210>3.0.CO;2-5     Document Type: Article

References (27)

1. The integration of chemotherapy into the management of locally advanced cervical cancer: A pilot study
2. A possible new trend in the management of the carcinomas of the cervix uteri
3. Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer
4. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: A pilot study
5. Two‐year survival: Preoperative adjuvant chemotherapy in the treatment of cervical cancer Stages IB and II with bulky tumor
6. Long term results of treatment of carcinoma of cervix
7. Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma
8. Results of radiation therapy given after radical hysterectomy
9. Randomized Phase III trial of neoadjuvant chemotherapy and radiotherapy versus radiotherapy in Stage IIB, IIIB carcinoma of the cervix (Abstr)
10. Randomized trial of neoadjuvant chemotherapy followed by pelvic radiotherapy versus radiotherapy alone in Stage IIIB carcinoma of the cervix (Abstr)
11. Four years' experience in the treatment of carcinoma of the cervix uteri with neoadjuvant chemotherapy
12. Five classes of extended hysterectomy for women with cervical cancer
13. Epidermal growth factor receptor in human breast cancer correlation with steroid hormone receptors and axillary lymph node involvement
14. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma
15. Regression models and life tables
16. Non parametric estimation from incomplete observations
17. Evaluating differences in survival between two groups of patients
18. Pharmacologic rationale for regional drug delivery
19. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix
20. Tumor antigen TA‐4 in the detection of recurrence in cervical squamous carcinoma
21. Tumor‐associated TA‐4 in the monitoring of the effects of the therapy for squamous cell carcinoma of the uterine cervix
22. Squamous cervical cancer at Stage IB and II: A 10 years' experience, analysis of 231 cases
23. Prognostic significance of the depth of invasion relating to nodal metastases, parametrial extension, and cell types: A study of 268 cases with Stage IB, IIA and IIB cervical carcinoma
24. The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of cervix
25. Tumor cell drug and radiation resistance: Does an interrelationship exist?